| |
| |
|
| Insider
Information: |
Kovacs Shane William Charles |
| Relationship: |
|
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
522,837 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,272,517 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
522,837 |
|
|
| Total
Value |
$1,272,517 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
Chief Financial Officer |
2017-05-09 |
37,850 |
|
0 |
Premium* |
|
|
Olema Pharmaceuticals, Inc. |
OLMA |
|
2024-01-12 |
484,987 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OLMA |
Olema Pharmaceuticals, In... |
CH. OPERATING & FINANCIAL OFF. |
• – – |
2024-01-12 |
4 |
OE |
$7.02 |
$351,000 |
D/D |
50,000 |
484,987 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
CH. OPERATING & FINANCIAL OFF. |
• – – |
2023-12-12 |
4 |
OE |
$7.02 |
$70,200 |
D/D |
10,000 |
434,987 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
CH. OPERATING & FINANCIAL OFF. |
• – – |
2023-11-22 |
4 |
S |
$13.89 |
$127,024 |
D/D |
(9,145) |
424,987 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
CH. OPERATING & FINANCIAL OFF. |
• – – |
2023-11-21 |
4 |
S |
$14.83 |
$142,632 |
D/D |
(9,597) |
434,132 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
CH. OPERATING & FINANCIAL OFF. |
• – – |
2023-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
36,750 |
443,729 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
CH. OPERATING & FINANCIAL OFF. |
• – – |
2023-04-06 |
4 |
B |
$0.00 |
$0 |
D/D |
10,000 |
396,197 |
0.01 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
CH. OPERATING & FINANCIAL OFF. |
• – – |
2022-09-02 |
4 |
B |
$0.00 |
$0 |
D/D |
20,000 |
381,197 |
0.01 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
Ch. Operating & Financial Off. |
• – – |
2020-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
358,680 |
|
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
Ch. Operating & Financial Off. |
• – – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
358,680 |
358,680 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-05-09 |
4 |
OE |
$10.85 |
$108,500 |
D/D |
10,000 |
37,850 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
27,850 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2016-09-26 |
4 |
OE |
$10.85 |
$108,500 |
D/D |
10,000 |
18,850 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-05-22 |
4 |
AS |
$55.26 |
$4,570,814 |
D/D |
(82,491) |
8,850 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-05-22 |
4 |
OE |
$10.85 |
$1,158,632 |
D/D |
78,991 |
91,341 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-05-22 |
4 |
AS |
$14.74 |
$24,321 |
D/D |
(1,650) |
12,350 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial OfficerOfficer |
• – – |
2013-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,000 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
